The current landscape of diabetes management in Morocco predominantly involves conventional pharmacological treatments, such as insulin and oral hypoglycemic agents (e.g., metformin, sulfonylureas), commonly prescribed for type 2 diabetes [364]. This evidence concerns the gene INS and type 2 diabetes mellitus.